Home
ACLX
ACLX News

Latest Arcellx Inc. (ACLX) News on February 22, 2025

Is Arcellx (ACLX) Poised to Capture Significant Market Share?

Insider Monkey

3 days ago

Is Arcellx (ACLX) Poised to Capture Significant Market Share?

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?

Zacks

a month ago

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 01/13/2025

MT Newswires

a month ago

Arcellx Insider Sold Shares Worth $2,263,942, According to a Recent SEC Filing

MT Newswires

a month ago

Arcellx Insider Sold Shares Worth $1,355,024, According to a Recent SEC Filing

Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?

Zacks

a month ago

Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?

MT Newswires

a month ago

Arcellx Insider Sold Shares Worth $2,244,896, According to a Recent SEC Filing

Arcellx Stock Earns 82 Relative Strength Rating

Investor's Business Daily

2 months ago

Arcellx Stock Earns 82 Relative Strength Rating

ASH 2024: Arcellx publishes positive results for Anito-cel in multiple myeloma

Clinical Trials Arena

2 months ago

ASH 2024: Arcellx publishes positive results for Anito-cel in multiple myeloma

MT Newswires

2 months ago

Gilead Sciences, Arcellx's CAR-T Therapy Supports 2030 Oncology Ambitions, Oppenheimer Says

MT Newswires

2 months ago

UBS Raises Price Target on Arcellx to $114 From $106, Maintains Buy Rating

Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead.

Investor's Business Daily

2 months ago

Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead.

MT Newswires

2 months ago

Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday

MT Newswires

2 months ago

Sector Update: Health Care

Benzinga

2 months ago

Arcellx's Cancer Cell Therapy Shows Deep, Durable Responses With Manageable Safety Profile In Heavily Pretreated Blood Cancer Patients

MT Newswires

2 months ago

Arcellx Says Trial of Multiple Myeloma Drug Candidate Achieves 97% Overall Response Rate

$Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition$

Business Wire

2 months ago

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and Exposition

Are You Looking for a Top Momentum Pick? Why Arcellx, Inc. (ACLX) is a Great Choice

Zacks

3 months ago

Are You Looking for a Top Momentum Pick? Why Arcellx, Inc. (ACLX) is a Great Choice

MT Newswires

3 months ago

Arcellx Insider Sold Shares Worth $1,242,170, According to a Recent SEC Filing

Arcellx Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

3 months ago

Arcellx Third Quarter 2024 Earnings: Misses Expectations

Is Arcellx (ACLX) Outperforming Other Medical Stocks This Year?

Zacks

3 months ago

Is Arcellx (ACLX) Outperforming Other Medical Stocks This Year?

Arcellx, Inc. (ACLX) Reports Q3 Loss, Lags Revenue Estimates

Zacks

3 months ago

Arcellx, Inc. (ACLX) Reports Q3 Loss, Lags Revenue Estimates

Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights

Business Wire

3 months ago

Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights

Arcellx price target raised to $106 from $81 at Morgan Stanley

TipRanks

3 months ago

Arcellx price target raised to $106 from $81 at Morgan Stanley

Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?

Zacks

3 months ago

Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?

MT Newswires

4 months ago

Morgan Stanley Adjusts Arcellx's Price Target to $106 From $81, Keeps Overweight Rating

$Arcellx to Present Clinical Data for Its Phase 1 and iMMagine-1 Studies in Patients with Relapsed or Refractory Multiple Myeloma at the 66th ASH Annual Meeting and Exposition and Announces Progress in iMMagine-3 Study$

Business Wire

4 months ago

Arcellx to Present Clinical Data for Its Phase 1 and iMMagine-1 Studies in Patients with Relapsed or Refractory Multiple Myeloma at the 66th ASH Annual Meeting and Exposition and Announces Progress in iMMagine-3 Study

Cancer cell therapy from Arcellx, Gilead shows promise in early data

BioPharma Dive

4 months ago

Cancer cell therapy from Arcellx, Gilead shows promise in early data

Arcellx (ACLX) Surged in Q3. Here’s Why

Insider Monkey

4 months ago

Arcellx (ACLX) Surged in Q3. Here’s Why

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?

Zacks

4 months ago

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?

MT Newswires

4 months ago

Redburn Initiates Arcellx at Buy With $109 Price Target

MT Newswires

6 months ago

Arcellx Insider Sold Shares Worth $1,840,053, According to a Recent SEC Filing

MT Newswires

6 months ago

Cantor Fitzgerald Initiates Arcellx at Overweight

MT Newswires

6 months ago

UBS Trims Price Target on Arcellx to $77 From $78, Maintains Buy Rating

Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates

Zacks

6 months ago

Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates

Arcellx Provides Second Quarter 2024 Financial Results and Business Updates

Business Wire

6 months ago

Arcellx Provides Second Quarter 2024 Financial Results and Business Updates

MT Newswires

7 months ago

Arcellx Insider Sold Shares Worth $1,208,435, According to a Recent SEC Filing

Here’s Why Arcellx (ACLX) Slipped in Q2

Insider Monkey

7 months ago

Here’s Why Arcellx (ACLX) Slipped in Q2

A Look At The Intrinsic Value Of Arcellx, Inc. (NASDAQ:ACLX)

Simply Wall St.

7 months ago

A Look At The Intrinsic Value Of Arcellx, Inc. (NASDAQ:ACLX)

GuruFocus.com

8 months ago

Insider Sale: CFO Michelle Gilson Sells 12,877 Shares of Arcellx Inc (ACLX)

We Think Arcellx (NASDAQ:ACLX) Can Easily Afford To Drive Business Growth

Simply Wall St.

8 months ago

We Think Arcellx (NASDAQ:ACLX) Can Easily Afford To Drive Business Growth

Arcellx Stock Earns Relative Strength Rating Upgrade

Investor's Business Daily

8 months ago

Arcellx Stock Earns Relative Strength Rating Upgrade

MT Newswires

8 months ago

Arcellx Insider Sold Shares Worth $1,102,668, According to a Recent SEC Filing

MT Newswires

9 months ago

Piper Sandler Starts Arcellx With Overweight Rating, $70 Price Target

Insider Sale: CFO Michelle Gilson Sells Shares of Arcellx Inc (ACLX)

GuruFocus.com

9 months ago

Insider Sale: CFO Michelle Gilson Sells Shares of Arcellx Inc (ACLX)

MT Newswires

9 months ago

Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating

MT Newswires

9 months ago

Evercore ISI Starts Arcellx With Outperform Rating

Arcellx First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

9 months ago

Arcellx First Quarter 2024 Earnings: Beats Expectations

GuruFocus.com

9 months ago

Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge

Kite and Arcellx prepare to launch Phase III multiple myeloma trial

Clinical Trials Arena

9 months ago

Kite and Arcellx prepare to launch Phase III multiple myeloma trial

Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates

Zacks

9 months ago

Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates

Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

Business Wire

9 months ago

Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

Business Wire

9 months ago

Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

Arcellx Provides First Quarter 2024 Financial Results

Business Wire

9 months ago

Arcellx Provides First Quarter 2024 Financial Results

Arcellx to Participate in Two Upcoming Investor Conferences

Business Wire

9 months ago

Arcellx to Participate in Two Upcoming Investor Conferences

MT Newswires

10 months ago

Arcellx Insider Sold Shares Worth $932,557, According to a Recent SEC Filing

Should You Be Bullish on Arcellx (ACLX)?

Insider Monkey

10 months ago

Should You Be Bullish on Arcellx (ACLX)?

Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Business Wire

a year ago

Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference

How Arcellx (ACLX) Stock Stands Out in a Strong Industry

Zacks

a year ago

How Arcellx (ACLX) Stock Stands Out in a Strong Industry

Dell, Dun & Bradstreet, Diebold Nixdorf, and More Stocks See Action From Activist Investors

Barrons.com

a year ago

Dell, Dun & Bradstreet, Diebold Nixdorf, and More Stocks See Action From Activist Investors

Insiders Are Dumping These 10 Healthcare Stocks

Insider Monkey

a year ago

Insiders Are Dumping These 10 Healthcare Stocks

Insider Sell: Arcellx Inc's Chief Medical Officer Christopher Heery Disposes of 46,815 Shares

GuruFocus.com

a year ago

Insider Sell: Arcellx Inc's Chief Medical Officer Christopher Heery Disposes of 46,815 Shares

Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

Business Wire

a year ago

Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

Earnings Update: Arcellx, Inc. (NASDAQ:ACLX) Just Reported And Analysts Are Boosting Their Estimates

Simply Wall St.

a year ago

Earnings Update: Arcellx, Inc. (NASDAQ:ACLX) Just Reported And Analysts Are Boosting Their Estimates

Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference

PR Newswire

a year ago

Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference

Arcellx, Inc. (ACLX) Q4 Earnings and Revenues Surpass Estimates

Zacks

a year ago

Arcellx, Inc. (ACLX) Q4 Earnings and Revenues Surpass Estimates

Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights

PR Newswire

a year ago

Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights

The 3 Biotech Stocks That Could Make Your February Unforgettable

InvestorPlace

a year ago

The 3 Biotech Stocks That Could Make Your February Unforgettable

Associated Press Finance

a year ago

Kemper: Q4 Earnings Snapshot

Kemper Reports Fourth Quarter 2023 Operating Results*

Business Wire

a year ago

Kemper Reports Fourth Quarter 2023 Operating Results*

Investors Could Be Concerned With Algonquin Power & Utilities' (TSE:AQN) Returns On Capital

Simply Wall St.

a year ago

Investors Could Be Concerned With Algonquin Power & Utilities' (TSE:AQN) Returns On Capital

Arcellx, Inc. (NASDAQ:ACLX) Shares Could Be 40% Below Their Intrinsic Value Estimate

Simply Wall St.

a year ago

Arcellx, Inc. (NASDAQ:ACLX) Shares Could Be 40% Below Their Intrinsic Value Estimate

4 Consumer Product Stocks to Keep an Eye On Amid Industry Woes

Zacks

a year ago

4 Consumer Product Stocks to Keep an Eye On Amid Industry Woes

Advance Auto Parts (AAP) Ascends While Market Falls: Some Facts to Note

Zacks

a year ago

Advance Auto Parts (AAP) Ascends While Market Falls: Some Facts to Note

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

CNW Group

a year ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

GlobeNewswire

a year ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

GlobeNewswire

a year ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

GlobeNewswire

a year ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

University of Nebraska Foundation Signs Five-Year Renewal with Blackbaud to Power Fundraising and Financial Management

PR Newswire

a year ago

University of Nebraska Foundation Signs Five-Year Renewal with Blackbaud to Power Fundraising and Financial Management

Should You Buy Chubb (CB) Ahead of Earnings?

Zacks

a year ago

Should You Buy Chubb (CB) Ahead of Earnings?

Beat the Market the Zacks Way: Rolls-Royce, Costco, e.l.f. Beauty in Focus

Zacks

a year ago

Beat the Market the Zacks Way: Rolls-Royce, Costco, e.l.f. Beauty in Focus

Here's the big investing lesson from sloppy earnings reports out of Tesla, Intel, Levi's, Citi, and others

Yahoo Finance

a year ago

Here's the big investing lesson from sloppy earnings reports out of Tesla, Intel, Levi's, Citi, and others

Buy Netflix Stock, Hold Off on Boeing

Barrons.com

a year ago

Buy Netflix Stock, Hold Off on Boeing

Rockwell Automation (ROK) Declines More Than Market: Some Information for Investors

Zacks

a year ago

Rockwell Automation (ROK) Declines More Than Market: Some Information for Investors

Intuitive Surgical (ISRG) Seeks FDA Nod for Next-Gen da Vinci 5

Zacks

a year ago

Intuitive Surgical (ISRG) Seeks FDA Nod for Next-Gen da Vinci 5

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Zacks

a year ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

A Look At The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)

Simply Wall St.

a year ago

A Look At The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)

Thomson Reuters StreetEvents

a year ago

Q2 2024 Seagate Technology Holdings PLC Earnings Call

Jim Cramer is Recommending These 10 Stocks

Insider Monkey

a year ago

Jim Cramer is Recommending These 10 Stocks

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

a year ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Cathay General Bancorp (NASDAQ:CATY) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Cathay General Bancorp (NASDAQ:CATY) Q4 2023 Earnings Call Transcript

What Makes Alight (ALIT) a Worthy Investment?

Insider Monkey

a year ago

What Makes Alight (ALIT) a Worthy Investment?

Intapp Inc Chief Marketing Officer Scott Fitzgerald Sells 16,454 Shares

GuruFocus.com

a year ago

Intapp Inc Chief Marketing Officer Scott Fitzgerald Sells 16,454 Shares

GuruFocus.com

a year ago

SLM Corp (SLM) Reports Solid Earnings Growth and Share Repurchase Program

Associated Press Finance

a year ago

Sallie Mae: Q4 Earnings Snapshot

New York Community Bancorp (NYCB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

a year ago

New York Community Bancorp (NYCB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Associated Press Finance

a year ago

United Community Banks: Q4 Earnings Snapshot

Has Ingersoll Rand Inc.'s (NYSE:IR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Simply Wall St.

a year ago

Has Ingersoll Rand Inc.'s (NYSE:IR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

United Community Banks, Inc. Reports Fourth Quarter Results

GlobeNewswire

a year ago

United Community Banks, Inc. Reports Fourth Quarter Results

Online Marketplace Stocks Q3 Teardown: Shutterstock (NYSE:SSTK) Vs The Rest

StockStory

a year ago

Online Marketplace Stocks Q3 Teardown: Shutterstock (NYSE:SSTK) Vs The Rest

Share on Social Networks: